Arch, J.R., A.T. Ainsworth, M.A. Cawthorne, V. Piercy, M.V. Sennitt, V.E. Thody, C. Wilson, and S. Wilson (1984) Atypical beta-adrenoreceptor on brown adipocytes as target for anti-obesity drugs. Nature, 309: 163-165.
Clegg, J.B. (1994) Travels with DNA in the Pacific. Lancet, 344: 1070-1072.
Clément, K., C. Vaisse, B.S.J. Manning, A. Basdevant, B. Guy-Grand, J. Ruiz, K.D. Silver, A.R. Shuldiner, P. Froguel, and A.D. Strosberg (1995) Genetic variation in the ß3-adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity. New England Journal of Medicine, 333(6): 352-354.
Dowse, G.K., P.Z. Zimmet, C.F. Finch, and V.R. Collins (1991) Decline in incidence of epidemic glucose intolerance in Nauruans: Implications for the "thrifty genotype." American Journal of Epidemiology, 133(11): 1093-1104.
Emorine, L.J., S. Marullo, M-M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko, and A.D. Strosberg (1989) Molecular characterization of the human ß3-adrenergic receptor. Science, 245: 1118-1121.
Gagnon, J., P. Mauriège, S. Roy, D. Sjöström, Y.C. Chagnon, F.T. Dionne, J-M. Oppert, L. Pérusse, L. Sjöström, and C. Bouchard (1996) The Trp64Arg mutation of the ß3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec family study and Swedish obese subjects cohorts. Journal of Clinical Investigation, 98(9): 2086-2093.
Inoue, I., T. Nakajima, C.S. Williams, J. Quackenbush, R. Puryear, M. Powers, T. Cheng, E.H. Ludwig, A.M. Sharma, A. Hata, X. Jeunemaitre, and J-M. Lalouel (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. Journal of Clinical Investigation, 99(7): 1786-1797.
Kadowaki, H., K. Yasuda, K. Iwamoto, S. Otabe, K. Shimokawa, K. Silver, J. Walston, H. Yoshinaga, K. Kosaka, N. Yamada, Y. Saito, R. Hagura, Y. Akanuma, A. Shuldiner, Y. Yazaki, and T. Kadowaki (1995) A mutation in the ß3-adrenergic-receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochemical and Biophysical Research Communications, 215(2): 555-560.
Mascie-Taylor, C.G.N. [Ed.] (1993) The anthropology of disease. Oxford University Press, Oxford, pp.16, 63-65.
Neel, J.V. (1963) Diabetes Mellitus: A "thrifty" genotype rendered detrimental by "progress"? American Journal of Human Genetics, 14: 353-362.
O'Dea, K. (1984) Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes, 33: 596-603.
Sicree, R.A., J.J. Hoet, P. Zimmet, H.O. King, and J.S. Coventry (1986) The association of non-insulin-dependent diabetes with parity and still-birth occurrence amongst five Pacific populations. Diabetes Research and Clinical Practice, 2: 113-122.
Silver, K., J. Walston, Y. Wang, G. Dowse, P. Zimmet, and A.R. Shuldiner (1996) Molecular scanning for mutations in the ß3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 81: 4155-4158.
Walston, J., K. Silver, C. Bogardus, W.C. Knowler, F.S. Celi, S. Austin, B. Manning, A.D. Strosberg, M.P. Stern, N. Raben, J.D. Sorkin, J. Roth and A.R. Shuldiner (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the ß3-adrenergic-receptor gene. New England Journal of Medicine, 333(6): 343-347.
Weiss, K.M. (1993) Genetic variation and human disease: principles and evolutionary approaches. Cambridge University Press, Cambridge, pp. 199-200.
Widén, E., M. Lehto, T. Kanninen, J. Walston, A.R. Shuldiner, and L.C. Groop (1995) Association of a polymorphism in the ß3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. New England Journal of Medicine, 333(6): 348-351.
Yoshida, T., N. Sakane, T. Umekawa, M. Sakai, T. Takahashi, and M. Kondo (1995) Mutation of ß3-adrenergic-receptor gene and response to treatment of obesity. Lancet, 346: 1433-1434.